Kinnate Biopharma : Results of Operations and Financial Condition - Form 8-K
First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a... | April 17, 2023
Source: marketscreener.com
Stay updated with breaking news from Early Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a... | April 17, 2023